Stéphane Depil, founder and CEO of ErVaccine Technologies,  will give a talk  entitled “Human Endogenous Retrovirus  Represent a Source of Shared Tumor Epitopes Inducing High-Avidity Cytotoxic T cells for Cancer Immunotherapy” at INCIT 2022 congress (Session #1 “New concepts & new targets in Immunotherapy” planned on Monday 26 September at 4:30 pm)

For more information visit: INCIT 2022 congress